WHAT'S KNOWN ON THIS SUBJECT: Vitamin D is essential for bone health and for cardiovascular and immune function. In critically ill adults, vitamin D deficiency is common and associated with sepsis and with higher critical illness severity. The influence on pediatric critical illness is unclear.
Vitamin D is essential for bone health [1] [2] [3] [4] and optimal cardiovascular [5] [6] [7] [8] [9] [10] and innate immune [11] [12] [13] [14] [15] function. Levels of 25-hydroxy vitamin D (25(OH)D) are most often used to assess adequacy of vitamin D stores. Patients with levels ,20 ng/mL are commonly categorized as vitamin D deficient, 1, 16, 17 and treatment is initiated in children to prevent rickets. 16 Influenced by decreased vitamin D intake and decreased sun exposure, .60% of US children have insufficient levels of 25(OH)D (,30 ng/ mL), with 15% being deficient. [16] [17] [18] [19] The rising rate of vitamin D insufficiency and deficiency has alarmed some experts, 4, 16, [18] [19] [20] although others have questioned the clinical importance of 25(OH)D insufficiency. 21 The level of 25(OH)D needed foradequate immune and cardiovascular function is unclear. Vitamin D deficiency has been associated with increased viral respiratory infections [22] [23] [24] [25] [26] and sepsis [27] [28] [29] in children and adults. Supplementing Japanese schoolchildren with 1200 IU of vitamin D over winter months decreased influenza infections. 30 This could be because 25(OH)D influences production of cathelicidin hCAP-18, an anti-microbial peptide. 14, 31 Critically ill adult patients with sepsis have lower vitamin D levels, associated with lower cathelicidin levels. 28 Vitamin D deficiencyhasbeen associated with higher levels of admission illness severity in adult ICU patients. [32] [33] [34] Low 25(OH)D levels prehospitalization and at ICU admission have been associated with short-and long-term allcause mortality and bacteremia in critically ill adults. 27, 34, 35 The prevalence of vitamin D deficiency and its influence on critical illness severity in children is unknown. We aimed to establish the prevalence of vitamin D deficiency in a cohort of critically ill children and identify factors influencing 25(OH)D levels on admission to the pediatric ICU. We hypothesized that children with lower 25(OH)D levels would have higher illness severity and that levels would be lowest in PICU patients admitted for a life-threatening infection.
METHODS
We screened all children admitted to the medical-surgical PICUs from November 9, 2009 to November 9, 2010. Eligibility criteria included the following: (1) age ,21 years and (2) estimated PICU stay of $48 hours (excluding short-term monitoring patients) or admission due to a probable infection. Patients admitted to the cardiac ICU were excluded because of high incidence of cardiac bypass, which can lower 25 (OH)D levels. 36 The Children' s Hospital Boston institutional review board approved the study. After obtaining informed consent, parents or guardians were interviewed about their child' s racial and ethnic background, sun exposure, and intake of vitamin D-containing foods and supplements by using a questionnaire adapted from a previous vitamin D study. 16 Dose of vitamin D supplements (ergocalciferol or cholecalciferol) was obtained from parent report. Formula intake in diet was dichotomized as yes-no to account for inconsistency in daily intake amount between patients.
Blood was obtained as close as possible to PICU admission either by drawing fresh blood or retrieving samples of leftover plasma refrigerated in the hospital laboratory. All plasma was stored refrigerated, frozen at 280°C within 7 days, then shipped frozen in batch for analysis. A direct radioimmunoassay developed in the Hollis laboratory and manufactured by Diasorin Corporation (Stillwater, MN) was used to measure total circulating 25(OH)D and 1,25(OH) 2 D concentrations (interand intraassay coefficient of variation of 10%). 37 Height was not routinely collected to calculate BMI, so probable obesity was defined as admission weight .2 SD above the 50th percentile for age. Severity of illness in the first 24 hours was measured by using the Pediatric Risk of Mortality III (PRISM III) score. 38 Maximum level of vasopressor use during PICU stay was assessed by using the Sequential Organ Failure Assessment cardiovascular (CV-SOFA) score with 0-1: no vasopressors, 2: dopamine ,5 mcg/kg/min, 3: dopamine 5 to 15 mcg/kg/min or norepinephrine/ epinephrine ,0.1 mcg/kg/min, and 4: dopamine .15 mcg/kg/min or norepinephrine/epinephrine .0.1 mcg/ kg/min. 39 To determine infection status on admission, patients who had any cultures or viral testing performed on the PICU admission day, or with a diagnosis of a confirmed or suspected infection within 7 days before PICU admission, were reviewed by a critical care physician. Confirmed infection was defined as having a (1) culture of a pathogenic bacteria from blood, cerebrospinal fluid, or lung plus receipt of antibiotics; (2) positive fungal culture plus antifungal treatment; or (3) viral pathogen detected. Suspected infection included all patients meeting systemic inflammatory response syndrome or community acquired pneumonia criteria with negative microbial testing who received a course of antibiotic treatment. Severe septic shock was defined as confirmed or suspected infection with vasopressor therapy (CV-SOFA score $3) on PICU admission day. Levels of 25(OH)D were categorized as normal ($30 ng/mL), insufficient (,30 ng/mL), 26, 28 and deficient (,20 ng/ mL). 17, 40, 41 Data were managed by using REDCap (Research Electronic Data Capture) tools hosted at Children' s Hospital Boston. 42 In the most critically ill children, it was not possible to obtain prospective consent before or at PICU admission, so an accurate measurement of the child' s fluid status at the exact time when the blood was sampled during fluid resuscitation was determined not to be feasible. When we were not able to obtain consent at the time of ICU admission, previously obtained and stored excess laboratory samples were retrieved from the clinical laboratory. Therefore, in a post hoc analysis, we tested whether timing of the blood sample relative to PICU admission was related to 25(OH)D level. In a second post hoc analysis, we evaluated the influence of total fluid bolus volume within #12 hours before PICU admission on 25(OH)D level in subjects admitted from the emergency department, operating room, or inpatient ward at our institution.
To allow for the skewed distribution of 25(OH)D levels, we used the Spearman correlation coefficient to assess the association of 25(OH)D with continuous variables, the Mann-Whitney test for dichotomous variables, and the KruskalWallis test for multicategory variables. Patient characteristics associated with 25 (OH)D in univariate analysis (P # .10) were included in the multivariable model. We used multiple logistic regression to assess the influence of these risk factors on vitamin D deficiency, dichotomized at ,20 ng/mL. To model quartiles of PRISM-III score and the 4-level CV-SOFA score during PICU stay, we used ordinal multinomial logistic regression. SAS was used for all computations (version 9.2, SAS Institute, Cary, NC).
RESULTS
We screened 2366 patients admitted to the PICU between November 9, 2009, and November 9, 2010, and enrolled 511/818 (62.5%) eligible patients with a plasma specimen available close to PICU admission. Reasons for nonenrollment of eligible subjects included the following: (1) consent refusal (12.3%), (2) unavailable parents or guardians (14.7%), and (3) Table 1 shows the results of the univariate analyses of baseline factors present before PICU admission and their association with admission 25(OH) D levels. Children who were previously healthy and older children had lower 25 (OH)D levels. History of vitamin D supplementation, intake of enteral formula (which contained 30-134 IU vitamin D/ cup), and admission during summer were associated with higher 25(OH)D levels. We had reliable parental report on home dose in 48 of the 64 patients taking uni-vitamin D supplements in which the mean daily intake was 1320 IU. Although many multivitamins contain the recommended daily allowance of vitamin D (400 IU), some contain 100 to 200 IU per tablet, preventing accurate determination of daily vitamin D. The 29 children with probable obesity had lower 25(OH)D levels than the children with normal or low body weight for age (mean 17.7 vs 22.7 ng/mL, P = .009). History of renal disease before PICU admission was not associated with 25 (OH)D level; patients with an elevated creatinine level near PICU admission actually had higher 25(OH)D levels (median 24.6 vs 20 ng/mL, P , .0001).
In the multivariate analysis of 25(OH)D deficiency (Table 3 , model 1), past medical history was aggregated into 4 categories based on results of the univariate analyses: previously healthy, oncologic disorder, seizure disorder, and other chronic conditions. These categories were not significantly associated with 25(OH)D deficiency (P = .21). Independent factors associated with decreased risk of 25(OH)D deficiency were younger age, white race with nonHispanic ethnicity, summer season, vitamin D supplementation, and formula intake.
As shown in Table 2 , median 25(OH)D levels were not associated with the underlying reason for PICU admission which included confirmed or suspected life-threatening infection, although 25(OH)D levels were markedly lower in the 51 patients with severe septic shock. Each subgroup of infection was added to the regression model for 25(OH)D deficiency, including viral respiratory and septic shock; none had a significant effect alone or in aggregate. The 94 subjects diagnosed with lower respiratory tract infection (LRTI) had the same median 25(OH)D level (22.5 ng/mL) as those without, and addition of LRTI to the regression model of vitamin D deficiency revealed no significant relationship (P = .62).
Duration of mechanical ventilation during the PICU stay was not significantly associated with 25(OH)D (r = -0.1007, P = .10). The median PRISM-III raw score on admission day was 5 (IQR 0-11.5), and it was inversely correlated with 25(OH)D level (r = 20.23, P , .0001; see Fig 1A) . A multinomial logistic regression model was created with PRISM-III quartiles as the outcome, adjusted for factors known previous to PICU admission associated with 25(OH)D admission levels. As shown in Table 3 Fig 1B) . In the multinomial logistic regression model (Table 3 , model 3), lower admission 25(OH)D levels were associated with higher CV-SOFA scores, a 5 ng/mL decrease corresponding to a 1.13-fold increase in odds of belonging to the next higher category of CV-SOFA score (95% CI 1.01-1.27; P = .03). This effect remained after adjusting for severe septic shock (OR 1.16, 95% CI 1.02-1.31; P = .02).
The median timing of the first vitamin D sampling was 0.6 hours after PICU admission (IQR 25.3 to 9.7 hours). Timing of sampling was weakly inversely correlated with 25(OH)D level, r = 2.12, P = .009. Fluid bolus data were available on 374/511 patients (73.1%) who were transferred from the inpatient ward, operating room, or the emergency department at our hospital. The median fluid bolus before PICU admission was 22.2 mL/kg, which had a weak inverse correlation with 25 (OH)D level (r = 2.12, P = .01). 43 Inclusion of the fluid resuscitation data did not markedly influence the association between any of the risk factors for vitamin D deficiency on PICU admission; all remained significant. Inclusion of fluid resuscitation volume into the model for predicting PRISM-III score showed that although increased fluid bolus amounts were associated with rising admission illness severity (OR 1.11, 95% CI 1.07-1.16, P , .0001), 25(OH)D levels remained inversely associated with PRISM-III (OR 1.10, 95% CI 1.01-1.20, P = .03). Fluid bolus volume before PICU admission was not a significant predictor of maximal CV-SOFA score during the PICU stay (OR 1.04, 95% CI 0.99-1.09, P = .11) and was not tested as a potential confounder. levels were similar to the 215 patients with normal levels (median 22.7 vs 24.5 ng/mL, respectively, P = .47); the addition of this group had no effect on the regression models for PRISM-III or CV-SOFA scores.
DISCUSSION
We identified a high prevalence of vitamin D deficiency and insufficiency in critically ill children in this prospective cohort study. The 40% prevalence of vitamin D deficiency (31% deficiency in infants and toddlers, 46% in school-age children, 57% in adolescents) in our cohort of critically ill children is higher than was reported in the healthy US pediatric population (9% in toddlers, 18 17% in school age, 18 and 14% deficiency in adolescents 17 ) and in studies of pediatric outpatients in Boston (12.1% deficiency in infants and toddlers; 42% in healthy adolescents). 19, 35 Our high prevalence of vitamin D deficiency in critically ill children is more similar to that reported in adult ICU patients in France and Boston where $26% were reported as deficient. 27, 46 In contrast to our expectations, we did not find critically ill children with confirmed or suspected infections to have lower 25(OH)D levels than other critically ill patient groups, with the exception of children presenting in severe septic shock. Studies have shown a relationship between vitamin D levels and illness severity in infected children.
Children with LRTI had a higher risk of hospital admission if their 25(OH)D level was in the severely deficient range. 24 Children with acute LRTIs admitted to the PICU had lower 25(OH)D levels compared with children admitted to the ward. 25 Fluid resuscitation may explain the decreased vitamin D levels in children in septic shock. Studies in critically ill adults have shown an inverse relationship between outpatient vitamin D levels and illness severity and mortality in large adult cohorts. 27 Vitamin D levels have been shown to be stable over the hospital course in patients with malaria 47 and with acute myocardial infarction. 48 However, they have also been shown to decrease by 40% in adults patients with an inflammatory response after knee surgery without significant fluid resuscitation and to remain decreased by 20% after hospitalization. 49 Cardiac 
